Suchergebnisse - "Nandakumar, Krishnadas"

PubPharm (103)

31

A systematic review and meta‐analysis on the cardio‐protective activity of naringin based on pre‐clinical evidences

enthalten in: Phytotherapy Research | 2022

von Viswanatha, G. | Shylaja, H. | Keni, R. | +2

32

A comprehensive review on Sesamum indicum L. : Botanical, ethnopharmacological, phytochemical, and pharmacological aspects

enthalten in: Journal of ethnopharmacology | 2021

von Mili, A. | Das, S. | Nandakumar, K. | +1

33

Acteoside isolated from Colebrookea oppositifolia attenuates I/R brain injury in Wistar rats via modulation of HIF-1α, NF-κB, and VEGF pathways

enthalten in: Inflammopharmacology | 2021

von Viswanatha, G. | Shylaja, H. | Nandakumar, K. | +2

34

In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy

enthalten in: 3 Biotech | 2021

von Shah, A. | Shah, A. | Nandakumar, K. | +3

35

In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy

enthalten in: 3 Biotech | 2021

von Shah, A. | Shah, A. | Nandakumar, K. | +3

36

In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy

enthalten in: 3 Biotech | 2021

von Shah, A. | Shah, A. | Nandakumar, K. | +3

37

In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy

enthalten in: 3 Biotech | 2021

von Shah, A. | Shah, A. | Nandakumar, K. | +3

38

Acteoside isolated from Colebrookea oppositifolia attenuates I/R brain injury in Wistar rats via modulation of HIF-1α, NF-κB, and VEGF pathways

enthalten in: Inflammopharmacology | 2021

von Viswanatha, G. | Shylaja, H. | Nandakumar, K. | +2

39

Acteoside isolated from Colebrookea oppositifolia attenuates I/R brain injury in Wistar rats via modulation of HIF-1α, NF-κB, and VEGF pathways

enthalten in: Inflammopharmacology | 2021

von Viswanatha, G. | Shylaja, H. | Nandakumar, K. | +2

40

Acteoside isolated from Colebrookea oppositifolia attenuates I/R brain injury in Wistar rats via modulation of HIF-1α, NF-κB, and VEGF pathways

enthalten in: Inflammopharmacology | 2021

von Viswanatha, G. | Shylaja, H. | Nandakumar, K. | +2